Results 91 to 100 of about 60,311 (178)

Glycosylated Receptor-Binding-Domain-Targeting Mucosal Vaccines Protect Against SARS-CoV-2 Omicron and MERS-CoV

Vaccines
Background. The pathogenic coronaviruses (CoVs) MERS-CoV and SARS-CoV-2, which are responsible for the MERS outbreak and the COVID-19 pandemic, respectively, continue to infect humans, with significant adverse outcomes.
Xiaoqing Guan, Abhishek K. Verma, Qian Liu, Melissa Palacios, Abby E. Odle, Stanley Perlman, Lanying Du   +6 more
doaj   +1 more source

Treating MERS-CoV during an outbreak [PDF]

The Lancet Infectious Diseases, 2014
Coleman, Christopher M, Frieman, Matthew B   +1 more
openaire   +2 more sources

MERS-CoV: a global challenge [PDF]

The Lancet, 2013
openaire   +2 more sources

Structural Basis of MERS-CoV Receptor Interactions and Antibody Neutralisations. [PDF]

Rev Med Virol
Gavor E, Choong YK, Singh S, Sivaraman H, Yin ES, Sivaraman J.   +5 more
europepmc   +1 more source

Correction: Directed evolution of a stem-helix-targeting antibody enables MERS-CoV cross-neutralization through enhanced binding affinity. [PDF]

PLoS Pathog
PLOS Pathogens Staff.
europepmc   +1 more source

Identification of MERS-CoV in dromedary camels [PDF]

The Lancet Infectious Diseases, 2014
Ferguson, Neil M, Van Kerkhove, Maria D
openaire   +2 more sources

Bioprocess Development of a Human Monoclonal Antibody against MERS-CoV: Analytical and Preclinical Studies. [PDF]

Biomol Ther (Seoul)
Lim J, Lee H, Lee JY, Jo DG, Hong S, Lee SY, Park BK, Jeong Y, Seo J, Park S, Jung H, Park CK, Kim KC, Cho I.   +13 more
europepmc   +1 more source

Directed evolution of a stem-helix-targeting antibody enables MERS-CoV cross-neutralization through enhanced binding affinity. [PDF]

PLoS Pathog
Zhou P, Yuan M, Zhang Y, Limbo O, Song G, Zhao F, Liu H, He WT, Capozzola T, Callaghan S, Avillion G, Li X, Beutler N, Yong P, Anzanello F, Rogers TF, Burton DR, Jardine JG, Wilson IA, Andrabi R.   +19 more
europepmc   +1 more source

AI-Guided Binding Mechanisms and Molecular Dynamics for MERS-CoV. [PDF]

Int J Mol Sci
Kumar P, Chen L, Chen RY, Chen Y, Pouriyeh S, Chakma P, Mohd Abul Basher AR, Xie Y.   +7 more
europepmc   +1 more source

Rational design of an optimized ferritin nanoparticle vaccine targeting both SARS-CoV-2 and MERS-CoV. [PDF]

J Nanobiotechnology
Liu Y, Rao H, Wang N, Liu X, Chen T, Zhang B, Lai J, Shan J, Xiao S, Peng H, Zhu Y, Liang T, Liu S, Hu M, Xie L, Qiu G, Li X, Li Y, Ma X.   +18 more
europepmc   +1 more source